Skip to main content

Work with DiMe on an upcoming project

The 3Ps of Digital Endpoint Value | Public Launch Event


April 7, 2022


Jordan Silberman

Director of Clinical Analytics and Research, Digital Care Delivery at Anthem, Inc

Siavash Sarlati

Medical Director, Digital Technology at Anthem, Inc

Katrine Christensen

Global Value & Access at Biogen Digital Health

Bray Patrick-Lake

Senior Director, Strategic Partnerships at Evidation

Matthew Harker

Senior Director, Key Account Strategic Solutions at Evidation Health

Curren Katz

Senior Director, Data Science Portfolio Management at Johnson & Johnson

Ginger Haynes

Research Advisor, Global Patient Outcomes and Real World Evidence at Eli Lilly

Jiat Ling Poon

Director, Value, Evidence, and Outcomes at Eli Lilly and Company

Marissa Dockendorf

Executive Director, Head of Global Digital Analytics & Technologies at Merck

Evlogi Itsev

Executive Director Marketing, New Product Leader Neuroscience & Pain Portfolio at Merck

Ritesh Kumar


David Kuczenski

Senior Director, Commercial Development, Internal Medicine at Pfizer

Mariah Leach

Patient Advocate


Jen Goldsack

CEO at DiMe Society

Discussion Topic

Our industry has spent years working to develop the evidentiary best practices to try and ensure that regulators accept evidence from digital endpoints in support of new drug approvals. But, to date, we’ve thought very little about how payers and HTAs may consider data from digital endpoints in reimbursement and pricing decisions.

In this webinar, DiMe and our partners from Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer, and Savvy Co-op introduced a new suite of resources to support evidence generation strategies for the use of data generated by digital endpoints in value and reimbursement discussions for new drugs.

View 3Ps Webinar Slide Deck

Listen to the recording

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today